Free Communication Orals #1: Technology & New Treatments for Type 2 Diabetes
Tracks
Breakout 3: Central B&C
Wednesday, August 20, 2025 |
11:00 AM - 1:00 PM |
Central Room B&C |
Speaker
Dr David Oneal
Endocrinologist
St Vincent's Hospital
Impact of re-cellularization via electroporation therapy on Continuous Glucose Monitoring (CGM) metrics in Type 2 diabetes: Insights from the REGENT-1 trial
11:00 AM - 11:15 AMBiography
Dr John Apostolopoulos is a research fellow with the Diabetes Technology Research Group based at the University of Melbourne.
Dr Ted Wu
Senior Specialist Endocrinologist And Director Of The Diabetes Centre
Royal Prince Alfred Hospital
Weight reduction with tirzepatide use by baseline HbA1c category in adults with overweight or obesity and type 2 diabetes in SURMOUNT-2
11:15 AM - 11:30 AMBiography
Dr Ted Wu is a senior specialist endocrinologist and the Director of the Diabetes Centre at The Royal Prince Alfred Hospital in Sydney, Australia - an International Diabetes Federation “Centre of Education” and National Association of Diabetes Centres “Centre of Excellence. He is also an Honorary Professor at the Shijiazhuang Diabetes Hospital in Hebei, China.
Prof Elif Ekinci
Head Of Department, Medicine Melbourne Medical School
University of Melbourne
Pulsed electric field induced duodenal re-cellularization impact on insulin sensitivity and beta cell function: Results from REGENT-1, an open-label, prospective study in Type 2 diabetes
11:30 AM - 11:45 AMBiography
Professor Elif Ekinci is a clinician scientist and an academic endocrinologist working to translate research into improved outcomes for people with type 1 and type 2 diabetes. Her research is focused on the pathophysiology, prevention, detection and treatment of diabetes and its complications in humans.
Dr David Oneal
Endocrinologist
St Vincent's Hospital
Effects of energy dosing on efficacy and safety in an open-label study of endoscopic pulsed electric field induced electroporation in type 2 Diabetes (REGENT-1 trial)
11:45 AM - 12:00 PMBiography
David O'Neal is a clinical researcher with an interest in diabetes technology and metabolic control. He has appointments with the University of Melbourne, St Vincent's Hospital Melbourne and the Baker Institute
Prof Richard MacIsaac
Physician
Epworth Richmond
Association of tirzepatide with kidney parameters in people with obesity and prediabetes from SURMOUNT-1 over 176 weeks
12:00 PM - 12:15 PMBiography
Richard MacIsaac is a clinician-researcher who is currently Professor and Director of Endocrinology and Diabetes at St Vincent’s Hospital Melbourne and the University of Melbourne, Victoria, Australia. He is also the diabetes kidney disease co-stream leader for the Australian Centre for Accelerating Diabetes Innovations (ACADI), University of Melbourne.
Assoc Prof Samantha Hocking
Associate Professor Diabetes Australia
University of Sydney
Change in body composition with tirzepatide in adults with early-onset obesity in SURMOUNT-1
12:15 PM - 12:30 PMBiography
Associate Professor Samantha Hocking is an Endocrinologist at Royal Prince Alfred Hospital and a Clinical Academic at the University of Sydney. She is a member of the Australian and New Zealand Obesity Society (ANZOS) Council and the current president of the National Association of Clinical Obesity Services (NACOS).
Dr Sophie Poulter
Endocrinologist
Queensland Health
Limited weight regain from nadir weight in SURMOUNT-1 3-year study
12:30 PM - 12:45 PMBiography
Dr. Sophie Poulter is Director of Obstetric Medicine, Senior Endocrinologist at Sunshine Coast University Hospital and senior lecturer at Griffith University. Her research focus is technology use for diabetes in pregnancy. She is a recent ex-chair of the QCDN Diabetes in Pregnancy group and has coauthored multiple statewide guidelines.
Assoc Prof Samantha Hocking
Associate Professor Diabetes Australia
University of Sydney
Reduction in cardiovascular events with icosapent ethyl in patients with diabetes and prior CABG: REDUCE-IT Diabetes-Prior CABG
12:45 PM - 1:00 PMBiography
Associate Professor Samantha Hocking is an Endocrinologist at Royal Prince Alfred Hospital and a Clinical Academic at the University of Sydney. She is a member of the Australian and New Zealand Obesity Society (ANZOS) Council and the current president of the National Association of Clinical Obesity Services (NACOS).
A/Prof Hocking’s research interests are focused on the metabolic complications of obesity. She is passionate about education to improve the quality of obesity care in Australia. In addition, she treats patients at the Metabolism and Obesity Service, Royal Prince Alfred Hospital.
Prof Elif Ekinci
Head Of Department, Medicine Melbourne Medical School
University of Melbourne
Chairperson
Biography
Assoc Prof Tongzhi Wu
Associate Professor
The University of Adelaide
Chairperson
Biography
